Related Articles
Identification of a 3‑mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3
PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming
Identification of a five‑gene signature for predicting the progression and prognosis of stage I endometrial carcinoma
Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma
Prognostic values of transketolase family genes in ovarian cancer